Healthcare Sector and Stocks Analysis from Seeking Alpha
Thu, 12 Jan 2012
By James Stocklasar Thomas Jr. : Mid-range biotechs like the ones mentioned in here are the most tempting buyout targets. They are Questcor-like ( QCOR ) in their forward vision to win enviable investment from the major institutions. Questcor recently exploded from around $26/share to over ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.